Kala Pharmaceuticals Inc. - Articles and news items


Kala Pharmaceuticals announces positive results from Phase 3 trial of KPI-121 in cataract surgery

Industry news / 1 April 2015 / Victoria White

Kala has announced positive results from a Phase 3 clinical trial of KPI-121 for the treatment of patients who have undergone cataract surgery…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...